Dr Jason Lester

Biography

Dr Jason Lester is a senior Consultant Clinical Oncologist based in South Wales. He trained and qualified in United Medical and Dental Schools of Guy’s & St Thomas’s in 1993. He completed his general medical training in London and the South East of England before moving to Wales in 1997. He joined Velindre Cancer Centre in 1997 and completed his Clinical Oncology training in 2003.

Dr Lester was appointed as a consultant Oncologist in 2003, specialising in the management of lung (non-small cell, small cell, mesothelioma) and urological (prostate, kidney, bladder) cancers. His NHS practice is based in South East Wales, with clinics in The Royal Gwent Hospital Newport, University Hospital Llandough and Cardiff.

He is currently Chairman of the Rutherford Cancer Centre Local Medical Advisory Committee for Wales. He is also the Clinical Lead for the All Wales Prostate Cancer Brachytherapy Service and Director of Stepping Stones, the Wales-based lung cancer charity.

Dr Lester participates in a large number of clinical trials in both lung and urological cancer sites, and has published extensively in these fields. He is the lead investigator in the I-START trial, (dose escalated radiotherapy) and the SKOPOS trial, a vaccine trial in malignant pleural mesothelioma. He is responsible for prescribing and supervising the administration of radiotherapy, radioisotope treatment, cytotoxic chemotherapy and hormone therapy.

Find out more by visiting Dr Jason Lester's website: www.lester-oncology.org

* Within the website, links to external sites and resources may be provided by third parties. Links to such sites are provided purely for your information only. It is the responsibility of the third party organisation to ensure any content on their websites comply with all relevant laws and regulations. Such links should not be interpreted as approval by us of those linked websites or information you may obtain from them. We have no control over the contents of those sites or resources. Our full Website terms of use can be found here.